期刊文献+

针灸随机对照试验现场质量控制内容探讨——基于PICOST的质量控制内容和清单设计 被引量:10

On-site quality control of acupuncture randomized controlled trial:design of content and checklist of quality control based on PICOST
原文传递
导出
摘要 为有效保证针灸随机对照试验的质量,形成合理的现场质量控制内容和清单,分析了针灸随机对照试验的质量影响因素,综合考虑质量控制内容的科学性和现场操作的可行性,在国家"十一五"课题"中医药防治重大疑难疾病综合治疗方案优化与临床评价共性技术和质量控制研究"现场质量控制内容和清单基础上,提出以PICOST为核心内容开展针灸随机对照试验现场质量控制,尤其要注重对干预实施者技能(I)和盲态结局评价(O)的质量控制,并形成了现场质量控制清单,供课题承担单位参考。 To effectively guarantee quality of randomized controlld trial (RCT) of acupuncture and develop reasonable content and checklist of on-site quality control, influencing factors on quality of acupuncture RCT are analyzed and scientificity of quality control content and feasibility of on-site manipulation are put into overall considera- tion. Based on content and checklist of on-site quality control in National llth Five-Year Plan Project Optimization of Comprehensive Treatment Plan for TCM in Prevention and Treatment of Serious Disease and Clinical Assess- ment on Generic Technology and Quality Control Research, it is proposed that on-site quality control of acupunc- ture RCT should be conducted with PICOST (patient, intervention, comparison, out come, site and time) as core, especially on quality control of interveners skills and outcome assessment of blinding, and checklist of on-site quality control is developed to provide references for undertaking groups of the project.
出处 《中国针灸》 CAS CSCD 北大核心 2014年第2期183-185,共3页 Chinese Acupuncture & Moxibustion
基金 国家科技部"十二五"科技支撑项目:2012 BAI 24 B02
关键词 质量控制 PICOST 临床研究方法学 针灸 随机对照试验 quality control PICOST clinical research methodology, acupuncture~ randomized controlled trial (RCT)
  • 相关文献

参考文献12

二级参考文献47

  • 1王文,马丽媛,邹效漫.国际多中心临床试验的监查[J].中国临床药理学与治疗学,2004,9(7):835-837. 被引量:9
  • 2毕惠嫦,田少雷,陈孝,黄民.探讨药物临床试验标准操作规程的制订和管理[J].中国临床药理学杂志,2004,20(6):462-464. 被引量:26
  • 3刘建平.针刺临床试验中对干预措施报告的国际标准[J].中国中西医结合杂志,2005,25(6):556-558. 被引量:9
  • 4The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high risk hypertensive patients ran- domized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Anti- hypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT)[J]. JAMA, 2002,288:2981--2997.
  • 5Sever PS, Poulter NR, Dahlof B, et al. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension [J]. J Hypertens, 2009,27(5) : 947--954.
  • 6Lisheng L, Yuqing Z, Guozhang L, et al. The Felodipine Event Reduction (FEVER) study; A randomized long-term placebo controlled trial in Chinese hypertensive patients [J]. J Hypertens, 2005,23(12) : 2157--2172.
  • 7Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial[J]. Lancet, 2004,363 (9426) : 2022-- 2031.
  • 8Weber MA, Bakris GL, Dahlof B, et al. Baseline characteristics in the Avoiding Cardiovascular e vents through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk[J]. Blood Pressure, 2007,16 (1): 13-- 19.
  • 9国家食品药品监督管理局令(第3号).药物临床试验质量管理规范[S].2003年8月6号.
  • 10Medical Research Council. A framework for development and evaluation of RCTs for Complex Interventions to Improve Health[DB/OL]. http:.// www. mrc. ac. uk /Utilities/Documentrecord/index. htm? d = MRC003372.

共引文献28

同被引文献82

引证文献10

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部